OGN Organon & Co.
Price Chart
Executive Summary
Organon filed this DEFA14A as additional soliciting material in support of its pending acquisition by Sun Pharma for $14.00 per share in cash. The document is an employee-focused Q&A that reiterates deal terms, including one-year compensation and benefits protections, and confirms the path to a shareholder vote and regulatory approvals. This is a routine communication that does not change the deal's terms or probability of closing.
Actionable Insight
The DEFA14A contains no new financial or strategic information — it is a routine employee communication. The stock should trade near the $14.00 deal price with a small spread reflecting regulatory and timing risk. Monitor for the definitive proxy statement and any shareholder litigation that could delay or alter terms.
Key Facts
- Sun Pharma to acquire Organon for $14.00 per share in cash, representing a 103% premium
- Enterprise value of $11.75 billion
- Deal announced April 26, 2026; definitive merger agreement signed same day
- Organon remains independent until closing; shareholder vote and regulatory approvals in more than a dozen countries required
- Pre-2026 RSUs will fully accelerate and be paid out in cash at $14.00 per unit at closing
- Post-2026 RSUs will convert to cash-based awards at $14.00 per unit and continue vesting on original schedule
- Sun Pharma commits to one year of base salary, bonus, benefits, and severance protections for continuing employees
- Prior service at Organon will be credited for vesting, benefit accrual, and eligibility at Sun Pharma
Financial Impact
Deal valued at $11.75 billion enterprise value; $14.00 per share cash consideration
Risk Factors
- Regulatory approvals in multiple jurisdictions may delay or block closing
- Shareholder vote required; failure to obtain minimum vote could scuttle deal
- Competing acquisition proposals could emerge
- Stockholder litigation could result in costs or injunctions
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-194151 |
| Document: 0001193125-26-194151-index-headers.html | 0001193125-26-194151 |
| Document: 0001193125-26-194151-index.html | 0001193125-26-194151 |
| Document: 0001193125-26-194151.txt | 0001193125-26-194151 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
8d ago
|
PREM14A
| $13.37 $13.36 | ▼ −0.04% | ▲ +2.71% | $13.39 (+0.19%) |
|
Apr 30, 2026
5w ago
|
DEFA14A
| $13.25 $13.31 | ▲ +0.45% | ▼ −1.27% | $13.39 (+1.09%) |
|
Apr 30, 2026
5w ago
|
8-K
| $13.25 $13.31 | ▼ −0.45% | ▲ +1.27% | $13.39 (−1.09%) |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $13.32 $13.26 | ▼ −0.41% | ▼ −2.10% | $13.39 (+0.56%) |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $13.32 $13.26 | ▼ −0.41% | ▼ −2.10% | $13.39 (+0.56%) |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $13.16 $13.26 | ▲ +0.76% | ▲ +0.36% | $13.39 (+1.79%) |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $13.16 $13.26 | ▲ +0.76% | ▲ +0.36% | $13.39 (+1.79%) |
|
Apr 27, 2026
6w ago
|
8-K
| $13.16 $13.26 | ▲ +0.76% | ▲ +0.36% | $13.39 (+1.79%) |
|
Apr 24, 2026
6w ago
|
DEFA14A
| $13.16 $13.26 | ▲ +0.76% | ▲ +0.36% | $13.39 (+1.79%) |
|
Mar 6, 2026
13w ago
|
Court Ruling
| $6.56 $6.34 | ▼ −3.36% | ▼ −1.83% | $13.39 (+104.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access